Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01186133 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT01186133 · ClinicalTrials.gov record · last posted 2026-06-30

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Name: Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice — clinical trial record (NCT01186133)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: IRIS-DES

StatusRecruiting

PhaseNot specified

SponsorSeung-Jung Park

Started2009-01

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.

Amendment record 17 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 17 times since 2010-08-20; most recent amendment 2026-06-26. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2012-11-22

Status change Terminated→Recruitingv3

2011-05-13

Status change Recruiting→Terminatedv1

Trial Details

NCT Number	NCT01186133
Lead Sponsor	Seung-Jung Park Collaborators: CardioVascular Research Foundation, Korea
Conditions	Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty
Enrollment	50,000 participants
Start Date	2009-01
Primary Completion	2030-12 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-30